Published Date: 01-02-2019
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Pneumonia Testing Market, published by KBV research, The Global Pneumonia Testing Market size is expected to reach $1.8 billion by 2024, rising at a market growth of 9.2% CAGR during the forecast period.
The North America market would dominate the Global Pneumonia Testing Diagnostic Centers Market by Region 2024; growing at a CAGR of 7.4 % during the forecast period. The Europe market is expected to witness a CAGR of 7.9% during (2018 - 2024). Additionally, The Asia Pacific market is expected to witness a CAGR of 9.5% during (2018 - 2024).
The Analyzers market dominated the Global Pneumonia Testing Market by Type 2017, thereby, achieving a market value of $1,214.6 million by 2024. The Consumables market is expected to witness a CAGR of 9.9% during (2018 - 2024).
The Point-Of-Care (POC) Testing market dominated the Global Pneumonia Testing Market by Method 2017, growing at a CAGR of 8.6 % during the forecast period. The Immunodiagnostics market is expected to witness a CAGR of 9.3% during (2018 - 2024). Additionally, The Molecular Diagnostics market is expected to witness highest CAGR of 10.5% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.
Global Pneumonia Testing Market Segmentation
By End User
Thermo Fisher Scientific
Unique Offerings from KBV Research